Assertio Holdings (ASRT) Liabilities and Shareholders Equity (2019 - 2026)

Assertio Holdings' (ASRT) quarterly Liabilities and Shareholders Equity came in at $211.3 million in Q1 2026, down 26.23% year-on-year from $286.4 million in Q1 2025, and down 20.85% quarter-over-quarter from $267.0 million in Q4 2025.

Assertio Holdings (ASRT) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

Assertio Holdings has disclosed Liabilities and Shareholders Equity across 8 years of filings, most recently posting $211.3 million for Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $211.3 million, down 26.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 4.86% YoY), and the FY2025 annual result was $267.0 million, down 6.24% from the prior year.
  • Liabilities and Shareholders Equity came in at $211.3 million for Q1 2026 at Assertio Holdings, down from $267.0 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $414.3 million in Q1 2023 to a low of $211.3 million in Q1 2026.
  • The 5-year median for Liabilities and Shareholders Equity is $286.4 million (2025), against an average of $315.6 million.
  • Across the five-year window, Liabilities and Shareholders Equity advanced 26.75% in 2022 and slumped 31.94% in 2024, its largest moves.
  • Assertio Holdings' Liabilities and Shareholders Equity stood at $413.9 million in 2022, then sank by 30.8% to $286.4 million in 2023, then dropped by 0.59% to $284.7 million in 2024, then fell by 6.24% to $267.0 million in 2025, then fell by 20.85% to $211.3 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $211.3 million (Q1 2026), $267.0 million (Q4 2025), and $319.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 40.04 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 15.15 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 6.71 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 555.95 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 4.91 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 13.22 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.26 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 2.27 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.35 Bn
10 Assertio Holdings 150.94 Mn 79.37 Mn 7.22 Mn 211.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 211.30 Mn
Dec 31, 2025 266.97 Mn
Sep 30, 2025 319.78 Mn
Jun 30, 2025 273.78 Mn
Mar 31, 2025 286.43 Mn
Dec 31, 2024 284.73 Mn
Sep 30, 2024 276.00 Mn
Jun 30, 2024 279.44 Mn
Mar 31, 2024 281.97 Mn
Dec 31, 2023 286.42 Mn
Sep 30, 2023 380.03 Mn
Jun 30, 2023 405.18 Mn
Mar 31, 2023 414.27 Mn
Dec 31, 2022 413.91 Mn
Sep 30, 2022 323.34 Mn
Jun 30, 2022 321.98 Mn
Mar 31, 2022 339.14 Mn
Dec 31, 2021 326.55 Mn
Sep 30, 2021 299.31 Mn
Jun 30, 2021 312.02 Mn